Market Closed -
Other stock markets
|
After market 08:00:00 pm | |||
783.2 USD | +1.71% | 785.5 | +0.30% |
09:52am | Eli Lilly's diabetes drug tirzepatide gets approval in China | RE |
08:48am | Eli Lilly says its diabetes drug tirzepatide gets approval in China | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+34.35% | 705B | |
+31.01% | 583B | |
-3.49% | 364B | |
+20.15% | 332B | |
+6.19% | 291B | |
+15.17% | 238B | |
-3.03% | 210B | |
+10.43% | 209B | |
+9.21% | 169B | |
-0.90% | 162B |
- Stock Market
- Equities
- LLY Stock
- News Eli Lilly and Company
- (LLY) ELI LILLY AND COMPANY Expects Fiscal Year 2024 EPS Range $13.50 - $14.00